2.2 million fine for distributed management of medical waste
0 Comment(s) 9347 View(s) Dangerous Goods
The judges confirmed that the companies created joint ventures (temporary joint venture) "has been established without objective necessity or effectiveness of the medications and their impact on the public interest". Consenur and Cespa also presented together with an agreement "not winning" in Extremadura and promote the award to a third company.
The companies were fined in 2011 by the National Competition Commission (CNC), which established that between Cespa and Consenur existed agreements "for the formation of joint ventures with the object and effect of nullifying competition in the Communities of Castile - La Mancha, reduce in Valencia and keep allocating customers in Catalonia ".
Competition imposed a fine of 4.4 million Consenur 2.5 Cespa and 445,000 to Interlum (the company favored in Extremadura). The National Court lowered to 2.2 million fine to Consenur and this is the fine that has now confirmed the Supreme For Cespa, the Court reduced the fine to 569,925 euros and the Supreme did not admit the appeal filed by the company , confirming the sanction. The fined companies are engaged in the management of hazardous waste hospital waste, such as blood, sharp objects, vaccines, chemical waste and chemically contaminated materials that require special treatment, both in collection and transportation and disposal.